Figure 3 shows: TEM images of liposomal curcumin; a comparison of cell viabilities in the case of curcumin powders, liposomal curcumin powders, and gemcitabine; confocal laser scanning microscope (CLSM) images of A549 cells incubated with curcumin powders and liposomal curcumin powders; the lungs’ appearance; sections of lung tissue; VEGF expression for the lung cancer model in rats and lung cancer rats treated with liposomal curcumin powder; and the effect of different formulations on MDA (oxidation indicator) [78]. This evidence concerns the gene VEGFA and lung cancer.